Wesfarmers Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Wesfarmers
See the Bigger Picture
Wesfarmers’ BCG Matrix preview highlights where its core divisions—consumer retail, industrials, and resources—likely fall across Stars, Cash Cows, Question Marks, and Dogs, revealing cash-generation engines and growth opportunities. This snapshot teases strategic moves around capital allocation, portfolio pruning, and investment priorities. Purchase the full BCG Matrix to get quadrant-by-quadrant placements, data-backed recommendations, and editable Word and Excel deliverables that turn insight into action.
Stars
Kmart Anko Global Expansion
Kmart’s Anko private label holds a dominant ~35% share of Australia’s value apparel and homewares segment and has scaled to supply over 1,200 international wholesale accounts across NZ, UK and SEA by Q4 2025.
Global demand for affordable quality goods grew ~7% CAGR 2020–2025; Anko sits in a high-growth market but needs ~A$300–400m capex through 2026 to upgrade sourcing, logistics and quality control.
As of Nov 2025, Anko is Wesfarmers’ primary growth engine, contributing roughly 18% of group like-for-like retail volume growth while shifting strategy from domestic private label to a global product brand.
Wesfarmers Health Division
Following Wesfarmers' 2022 acquisition of Australian Pharmaceutical Industries (API), the Wesfarmers Health Division has seized ~6–8% incremental market share in retail pharmacy and beauty, driven by Priceline; Australian pharmacy sales hit A$25bn in 2024, with Priceline accounting for ~12% of category sales.
High sector growth—projected ~4–6% CAGR to 2028 for Australian healthcare retail and digital health—means heavy reinvestment in digital platforms and clinical services; Wesfarmers disclosed A$150–200m planned capex through 2026 for tech and pharmacy rollout.
With ageing demographics (Australia 65+ rising from 16% in 2024 to ~20% by 2035), scaling clinical and pharmacy services positions the division as a future profit engine, capable of contributing mid-to-high single-digit percentage points to Wesfarmers' group EBIT as penetration and services monetise.
Covalent Lithium Project
Mt Holland (Covalent Lithium Project) is a Stars BCG-matrix asset for Wesfarmers, now a major producer in the high-growth battery minerals market, with expected annual spodumene output ~200 ktpa and capital employed >A$1.2bn as of Dec 2025.
Despite lithium price swings (average battery-grade spodumene concentrate price ~US$3,200/t in 2025), strategic importance drives strong investor interest and ongoing internal capex.
Refinery optimization consumes substantial cash—Wesfarmers disclosed A$300–400m maintenance/capex in 2025—yet projected IRR >20% as EV global stock targets ~200M units by 2026 lift demand.
OneDigital and OnePass Ecosystem
OneDigital and OnePass consolidates Wesfarmers’ OnePass loyalty and shared data across brands to enable personalized digital experiences and higher retention; in 2025 the division targets >30% YoY growth in digital engagement and aims to increase group average basket by ~8% per member.
It sits in a high-growth digital data market worth AU$12–15bn in retail data services (2025 est.), facing competition from global tech platforms and local retailers; market share gains require sustained investment.
High capex for cloud, analytics, and privacy compliance pushes annual funding needs into the tens of millions AUD, but the platform delivers strategic differentiation and margin uplift for Wesfarmers’ retail brands.
- Integrates OnePass loyalty + shared data
- Targets >30% YoY digital engagement growth (2025)
- Estimated AU$12–15bn market (2025)
- Requires multi‑million AUD annual capex
- Drives ~8% basket uplift per member
Bunnings Commercial and Trade
Bunnings Commercial and Trade is a Star in Wesfarmers’ BCG matrix: while consumer DIY is mature, the commercial arm grew ~12% YoY in FY2024, outpacing the ~4% consumer hardware market and capturing more pro builder share during a housing upswing.
The segment needs specialized logistics and digital procurement platforms; Wesfarmers reported Bunnings trade sales of AUD 6.7bn in FY2024, signaling a strategic pivot to own high-value B2B construction supply chains.
- FY2024 trade sales AUD 6.7bn
- Segment growth ~12% YoY vs consumer ~4%
- Higher margin B2B contracts, requires logistics/digital tools
- Targets pro builders amid rising housing demand
High‑growth "Stars" (A$150–400m capex) delivering mid‑teens IRRs and 12–18% group growth
Stars: Anko, Mt Holland, Wesfarmers Health, OneDigital/OnePass, Bunnings Trade drive high growth; each needs significant capex (A$150–400m range) but offer mid-to-high teen IRRs and contribute 12–18% of group growth (2024–25 data).
| Asset | 2024–25 | Capex to 2026 (A$) | Role |
|---|---|---|---|
| Anko | ~35% value share; 18% LFL growth | 300–400m | Global private label scale |
| Mt Holland | ~200 ktpa spodumene | 300–400m | Battery minerals producer |
| Wesfarmers Health | Priceline ~12% category | 150–200m | Pharmacy/clinical growth |
| OnePass/OneDigital | ~30% YoY digital growth target | tens m p.a. | Loyalty/data platform |
| Bunnings Trade | AUD 6.7bn trade sales; 12% YoY | multi‑10s m | B2B growth engine |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix analysis of Wesfarmers’ portfolio with strategic actions for Stars, Cash Cows, Question Marks, and Dogs.
Customizable Excel Spreadsheet
One-page Wesfarmers BCG Matrix placing each business unit in a quadrant for quick portfolio decisions
Cash Cows
Bunnings Warehouse DIY Retail
Bunnings Warehouse leads Australia’s home improvement market with an estimated ~50% retail share in FY2024 and FY2025, delivering roughly A$4.8bn EBITDA in FY2024 and generating strong free cash flow vs low promotional spend.
Those cash flows funded Wesfarmers’ 2024–25 dividends and helped finance the ~A$2.9bn Coles-related capital returns and smaller acquisitions, and continue to subsidize higher-growth units within the group.
Officeworks Business Solutions
Officeworks Business Solutions holds a dominant share in Australia’s office-supplies and home-office tech market, operating in a mature sector where FY2024 sales were roughly A$2.1bn and like-for-like growth stabilized near 1–2%.
The unit emphasizes operational efficiency and marginal service upgrades—warehouse automation and B2B fulfilment improvements—keeping EBITDA margins around 10–12% and steady free cash flow.
It generates predictable liquidity with low capex (under A$40m in FY2024), funding Wesfarmers’ group initiatives and dividends without heavy reinvestment.
WesCEF Ammonium Nitrate
WesCEF Ammonium Nitrate sits as a cash cow in Wesfarmers’ BCG matrix: the chemicals branch serves a mature industrial market with high barriers and >30% assumed market share in Australian mining explosives supply as of 2025, locking long-term contracts with major miners that yielded ~A$320m EBITDA in FY2024 and steady free cash flow excluding periodic maintenance capex.
Kleenheat Energy Distribution
Kleenheat Energy Distribution, a Wesfarmers subsidiary, dominates LPG and natural gas retail in Western Australia and the Northern Territory with roughly 40–50% market share in key segments as of 2025; its mature market shows low single-digit annual growth, so management prioritises retention and cost control.
The unit delivers steady EBITDA margins near 12% and annual operating cash flow around A$60–80m (2024–25), helping Wesfarmers service corporate debt and fund A$30–40m in alternative-energy R&D.
- Established WA/NT market leader, ~40–50% share
- Market growth low, ~1–3% annual
- EBITDA margin ~12%
- OCF A$60–80m (2024–25)
- Funds A$30–40m alternative-energy R&D
Target Australia Refined Model
Post-restructure, Target Australia (integrated with Kmart Group under Wesfarmers since 2020) now yields steady margins from apparel and soft home; FY2024 sales for Kmart Group stores including Target were reported at ~A$7.9bn, with Target contributing a smaller, profitable share and gross margin improvement of ~2–3ppt versus 2021.
Lower cost base, curated range, and mature demographic mean Target needs less capital expenditure than Kmart, producing consistent free cash flow; Wesfarmers noted reduced inventory turns but improved ROIC to mid-teens for the segment in FY2024.
- Stable high-share in apparel/soft home
- Lower cost base, curated assortment
- Less capex, consistent free cash flow
- ROIC mid-teens (FY2024); part of ~A$7.9bn Kmart Group sales
Wesfarmers’ cash cows: Bunnings, Kmart/Target, Officeworks fuel strong FY24 cash flow
Bunnings, Officeworks, WesCEF AN, Kleenheat and Target (post-restructure) are Wesfarmers' cash cows, delivering steady EBITDA, low capex and strong free cash flow that fund dividends and group growth; FY2024 figures: Bunnings EBITDA ~A$4.8bn, Officeworks sales ~A$2.1bn, WesCEF EBITDA ~A$320m, Kleenheat OCF A$60–80m, Kmart Group (incl. Target) sales ~A$7.9bn.
| Unit | FY2024 | Key metric |
|---|---|---|
| Bunnings | EBITDA A$4.8bn | ~50% AU share |
| Officeworks | Sales A$2.1bn | EBITDA margin 10–12% |
| WesCEF AN | EBITDA A$320m | >30% mining share |
| Kleenheat | OCF A$60–80m | EBITDA margin ~12% |
| Target (Kmart) | Group sales A$7.9bn | ROIC mid-teens |
What You See Is What You Get
Wesfarmers BCG Matrix
The file you're previewing is the exact Wesfarmers BCG Matrix report you'll receive after purchase—no watermarks, no demo content—just a fully formatted, strategy-ready document built for clear portfolio analysis and decision-making.
Dogs
Catch Marketplace
Catch Marketplace is a Dog in Wesfarmers’ BCG matrix: by FY2024 it held an estimated low single-digit online market share in Australia versus Amazon’s ~35% and generated losses that compressed Group EBIT contribution to near zero.
Integration with OnePass has raised cross-sell but not profitability; customer acquisition costs remain high and GMV growth lagged peers—FY2024 GMV reportedly declined year-on-year.
Given weak margin conversion and disproportionate management time, Catch is a clear candidate for further restructuring or divestiture unless unit economics improve within 12–18 months.
Blackwoods Industrial Safety
Blackwoods Industrial Safety sits in Wesfarmers BCG Matrix Dogs: it competes in a fragmented industrial-safety market with ~1–2% annual growth and has lost share to digital entrants; FY2024 sales ~A$1.1bn with EBIT margin under 3%, down from 5% in 2019, showing persistent margin pressure.
Workwear Group Legacy Brands
Workwear Group Legacy Brands handles specialized uniforms and industrial clothing in a mature, low-growth market—Australian workwear market growth ~1–2% CAGR (2020–2024); intense price competition keeps margins thin.
It wins large corporate contracts but faces erosion from direct-to-factory sourcing; estimated share loss risk ~5–10% annually for major clients.
Within Wesfarmers it is low priority, often breakeven: FY2024 segment EBIT margin ~0–2%, limited strategic value.
Coregas New Zealand Operations
Coregas New Zealand operates as a niche Dogs-stage asset for Wesfarmers: market share under 5% in 2024 vs multinationals holding ~70%, annual revenues ~NZD 18m (2024), and local industrial gas market growth ~1–2% pa—too small to change conglomerate outcomes.
- Market share <5% (2024)
- Revenues ~NZD 18m (FY2024)
- Competitors hold ~70% share
- Market growth 1–2% pa
Regional Small Format Hardware
Certain legacy small-format hardware sites in Wesfarmers’ portfolio, not converted to Bunnings Warehouse, show low growth and falling foot traffic—sales per sqm down ~12% year-on-year in some regional catchments (FY2024 internal estate review) and market share under 5% locally.
They lose to larger category killers and online fulfillment, prompting frequent reviews for closure or conversion to higher-yield uses across the property portfolio.
- Sales per sqm down ~12% (FY2024 estate review)
- Local market share <5% in affected catchments
- High closure/conversion review rate in 2024–25
- Conversion targets aim to boost returns >15% IRR
Wesfarmers' FY24 Dogs: Low Share, Weak Growth Across Catch, Blackwoods, Workwear
Dogs: Catch, Blackwoods, Workwear legacy, Coregas NZ and small-format hardware are low-share, low-growth assets in Wesfarmers’ BCG matrix—FY2024 highlights: Catch low single-digit online share, GMV down; Blackwoods A$1.1bn revenue, EBIT <3%; Workwear EBIT ~0–2%; Coregas NZ revenue NZD18m, share <5%; estate sites sales/sqm −12%.
| Asset | FY2024 Rev/GMV | Market share | EBIT/ margins | Growth |
|---|---|---|---|---|
| Catch | low single-digit GMV | <5% | losses | declined |
| Blackwoods | A$1.1bn | — | <3% | ~1–2% |
| Workwear | — | — | 0–2% | 1–2% |
| Coregas NZ | NZD18m | <5% | — | 1–2% |
| Estate sites | — | <5% | — | sales/sqm −12% |
Question Marks
InstantScripts Telehealth Platform
InstantScripts, a recent Wesfarmers acquisition in the high-growth telehealth market, holds a small but fast-growing share—estimated ~2–3% of Australia’s digital prescriptions market in 2024 with revenue ~AUD 12m. It needs substantial tech and clinical governance capex—estimated AUD 8–12m over 2025–26—to scale and match startups. Its success hinges on integrating with Wesfarmers Health retail channels and MedAdvisor-like partners to drive user growth and reach profitability.
SILK Laser Clinics
The acquisition of SILK Laser Clinics (2024 purchase for A$92m) places Wesfarmers into the high-growth non-surgical aesthetics market, which McKinsey estimates at ~A$3.5bn in Australia (2024) but where SILK’s share is still single-digit within the broader A$10bn beauty services industry.
The sector is highly fragmented—~8,000 clinics nationally—so Wesfarmers needs substantial capital to consolidate; typical clinic roll-up deals cost A$0.5m–A$2m each.
If SILK leverages Priceline’s ~7.8m loyalty members and drives 20–30% same-store growth, it could scale fast and convert from Question Mark to Star within 3–5 years.
Green Hydrogen Pilot Projects
Wesfarmers, via WesCEF (Wesfarmers Chemicals, Energy & Fertilisers), is funding green hydrogen pilots to tap a projected global market worth US$1.4 trillion by 2050 (IEA, 2024); projects sit in a nascent, high-growth segment with near-zero Wesfarmers market share today.
These pilots burn R&D cash—WesCEF capital spend rose 18% to A$220m in FY2024—aiming to scale electrolysis and low-carbon feedstocks so Wesfarmers can target industrial decarbonisation leadership if commercialization succeeds.
Zitcha Retail Media Partnership
Zitcha Retail Media Partnership sits in Question Marks: Wesfarmers is entering retail ad tech to tap the global retail media market, projected at US$120bn in 2025 and ~A$1.5bn Australia ad spend growth; current internal estimates show low single-digit market share as Wesfarmers starts monetising >30m customer IDs for third-party ads, making this a high-risk, high-reward push for non-product revenue.
- Low market share: single-digit (%) within retail media
- Addressable market: global ~US$120bn (2025)
- Customer data: >30 million IDs across group
- Upside: higher margin ad revenue vs retail sales
- Risk: tech, privacy, advertiser take-up
SiSu Health Stations
SiSu Health Stations are a Question Mark in Wesfarmers BCG matrix: niche digital check kiosks tapping growing preventative health demand but holding <1% of Australia’s A$10.5bn diagnostic market (2024); revenues ~A$2.4m in FY2024 and pilot EBITDA negative, so high investment needed to scale.
Wesfarmers must choose: heavy nationwide rollout to target ~15–25% share of retail-based diagnostics (capex estimate A$40–80m over 3 years) or keep stations as low-cost pilots within existing stores to test user uptake and data monetisation.
- Market size: A$10.5bn diagnostics (2024)
- SiSu revenue: A$2.4m FY2024, <1% market share
- Rollout capex: est. A$40–80m (3 years)
- Potential share target: 15–25% of retail diagnostics
- Decision hinge: scale ROI vs. learn-and-experiment
Small Stakes, Big Markets: Portfolio Bets on Aesthetic, H2, Medtech & Retail Media
Question Marks: InstantScripts (2–3% share; AUD12m rev 2024; AUD8–12m capex 2025–26); SILK Laser (A$92m buy; single-digit share in A$3.5bn aesthetics); WesCEF green H2 pilots (WesCEF capex A$220m FY2024; near-zero share); Zitcha retail media (>30m IDs; global US$120bn 2025); SiSu Stations (A$2.4m rev 2024; <1% of A$10.5bn diagnostics; rollout capex A$40–80m).
| Asset | 2024–25 data | Key metric |
|---|---|---|
| InstantScripts | AUD12m rev | 2–3% market |
| SILK | A$92m buy | single-digit share |
| WesCEF H2 | A$220m capex | nascent |
| Zitcha | 30m IDs | global US$120bn |
| SiSu | A$2.4m rev | <1% diagnostics |